We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Unveils Data Standards Strategy for FY 2018-2022
FDA Unveils Data Standards Strategy for FY 2018-2022
CDER and CBER issued a joint data standards strategy detailing how the centers will develop and use data standards to review pre- and post-market safety and efficiency data through fiscal year 2022.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor